Propiedad y actividad de insiders de Bolt Biotherapeutics, Inc. (BOLT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.63 |
| Capitalización | $7M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $13.6M | $34.8M | $5.5M | $27.4M | $9.2M | $10.8M | $7.2M | $11.7M |
| Inversiones a Corto | 0 | 0 | $17.3M | $158.8M | $159.6M | $91.4M | $40.1M | $15.8M |
| Cuentas por Cobrar | 0 | $300000 | 0 | $200000 | 0 | 0 | $1.2M | $973000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $14.1M | $35.9M | $25.4M | $189.2M | $172.7M | $105.7M | $50.8M | $30.3M |
| Inmovilizado Material | $1.4M | $11.5M | $16.4M | $30.6M | $28.5M | $24.1M | $24.9M | $20.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.0M | $48.4M | $46.5M | $307.7M | $227.8M | $159.8M | $99.6M | $56.7M |
| Cuentas por Pagar | $892000 | $2.1M | $1.6M | $3.6M | $3.6M | $3.0M | $1.5M | $1.4M |
| Deuda a Corto | 0 | 0 | 0 | $2.5M | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.8M | $8.7M | $11.3M | $21.3M | $23.1M | $20.5M | $15.9M | $8.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $31.9M | $94.3M | $151.5M | $57.6M | $56.3M | $47.0M | $42.4M | $30.2M |
| Reservas | -$17.2M | -$47.7M | -$108.4M | -$207.0M | -$295.1M | -$364.3M | -$427.4M | -$460.8M |
| Patrimonio Neto | -$15.9M | -$45.8M | -$104.9M | $250.1M | $171.5M | $112.7M | $57.2M | $26.5M |
| Deuda Total | $40000 | $10.2M | $10.9M | $24.4M | $22.6M | $20.2M | $25.2M | $23.0M |
| Deuda Neta | -$13.6M | -$24.6M | -$12.0M | -$161.9M | -$146.3M | -$82.0M | -$22.1M | -$4.5M |
| Capital Circulante | $11.3M | $27.2M | $14.1M | $167.8M | $149.6M | $85.3M | $35.0M | $21.8M |
Salud financiera
| Deuda / Patrimonio | 1.71 |
| Ratio corriente | 2.61 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -12.58 |
Rentabilidad
| Rentabilidad sobre capital | -125.92% |
| Rentabilidad sobre capital invertido | -67.72% |
| Rentabilidad sobre activos | -58.81% |
| Margen bruto | 95.68% |
| Margen operativo | -623.04% |
| Margen neto | -611.47% |
Empresas relacionadas: AEON · CING · CLRB · EVGN · IMNN · INAB · LYRA
Explorar sector: Healthcare · Biotechnology
Más secciones de BOLT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones